Examining the medications associated with treating otitis externa symptoms
Brittany A. Lancellotti, DVM, DACVD, gave an overview of the risks and benefits of these systemic medications
While at the Fetch conference in Long Beach, California, Brittany A. Lancellotti, DVM, DACVD, sat down with dvm360 in an interview and explained the risks and benefits of systemic medications used for the treatment of allergic itch and inflammation associated with otitis externa.
The following is a partial transcript of the video.
Brittany A. Lancellotti, DVM, DACVD: Hi I'm Dr Brittany Lancellotti. I am a veterinary dermatologist at Veterinary Skin and Ear in Los Angeles, California.
There are lots of different medications that can be reached for when we are managing otitis externa. And some of the systemic medications that we typically use are going to be focused around the itch and inflammation that triggers the secondary infection...Each of these medications has its own benefits and risks and should be selected based on what that individual pet needs.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Zenrelia™ (ilunocitinib tablets): An Innovative, Once Daily Canine Treatment That Targets Itch
June 25th 2025Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help improve owner compliance and can be cost effective* for pet owners
Read More
